MedPath

Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis

Phase 2
Completed
Conditions
Meningitis, Cryptococcal
HIV Infections
Registration Number
NCT00012467
Lead Sponsor
InterMune
Brief Summary

The purpose of this study is to examine the antifungal activity of recombinant interferon-gamma 1b (rIFN-gamma 1b) given with standard antifungal therapy.

Detailed Description

Patients are randomized into 1 of 3 parallel groups for a 3-arm, 2-stage, double-blind and dose-ranging study for 14 weeks. In Stage 1, patients are hospitalized for 14 days of acute therapy. Patients receive rIFN-gamma 1b or placebo sc 3 times per week, intravenous (IV) AMB daily, and with or without oral 5-FC every 6 hours. Patients who have the ability to take oral medications, who do not have any significant clinical deterioration during the previous 14 days, and who meet the eligibility criteria can progress to Stage 2. In Stage 2 patients receive 84 days of consolidation therapy (56 days with study drug and 28 days of follow-up). On an outpatient basis, patients receive either placebo or 1 of 2 doses of rIFN-gamma 1b sc 3 times per week, and oral fluconazole daily or oral itraconazole 2 times a day.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (9)

Univ of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

Washington Univ

🇺🇸

St Louis, Missouri, United States

UMDNJ - New Jersey Med School / Cooper Hosp

🇺🇸

Camden, New Jersey, United States

Univ of Med & Dentistry of New Jersey

🇺🇸

Newark, New Jersey, United States

Houston Veterans Administration Med Ctr

🇺🇸

Houston, Texas, United States

Univ of Texas / Med School at Houston

🇺🇸

Houston, Texas, United States

Audie L Murphy Veterans Administration Hosp

🇺🇸

San Antonio, Texas, United States

Hosp Nacional dos de Mayo

🇵🇪

Lima, Peru

Instituto de Medicina Tropical

🇵🇪

Lima, Peru

Univ of Alabama at Birmingham
🇺🇸Birmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.